Literature DB >> 1542644

Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.

N D Perkins1, R M Schmid, C S Duckett, K Leung, N R Rice, G J Nabel.   

Abstract

The nuclear factor that binds to the kappa light-chain enhancer of B cells (NF-kappa B) is a transcription factor that regulates the expression of a variety of cellular and viral genes. NF-kappa B is composed of distinct subunits, and at least four independent genes (p105, p100, p65, and c-rel) have been isolated that encode related proteins that bind kappa B sites. Because it is possible that specific interactions of different subunits can allow selective gene activation, we have characterized the specificity of transcriptional activation by various combinations of these subunits. When tested alone, an approximately 49-kDa form (p49) of the p100 protein bound weakly to kappa B, but p49 associated with p65 to bind efficiently to this site. Furthermore, p49 acted in combination with either p65 or a Rel/VP16 fusion protein to activate kappa B-dependent transcription in Jurkat T leukemia cells. The p49/p65 or p49/Rel combination stimulated transcription mediated by the canonical kappa B site but did not stimulate reporter genes containing interleukin 2 receptor alpha or major histocompatibility complex kappa B elements, despite its ability to bind to these sites. Transactivation mediated by the p49/p100 and p65 NF-kappa B proteins is therefore sensitive to minor changes in the sequence of the kappa B site. Specificity determined by the association of NF-kappa B subunits provides a mechanism to selectively regulate variant kappa B sites associated with different cellular and viral genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542644      PMCID: PMC48485          DOI: 10.1073/pnas.89.5.1529

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.

Authors:  M Kieran; V Blank; F Logeat; J Vandekerckhove; F Lottspeich; O Le Bail; M B Urban; P Kourilsky; P A Baeuerle; A Israël
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

Authors:  S M Ruben; P J Dillon; R Schreck; T Henkel; C H Chen; M Maher; P A Baeuerle; C A Rosen
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

3.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 4.  NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.

Authors:  M J Lenardo; D Baltimore
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

5.  The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

Authors:  D W Ballard; W H Walker; S Doerre; P Sista; J A Molitor; E P Dixon; N J Peffer; M Hannink; W C Greene
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

6.  HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.

Authors:  D W Ballard; E Böhnlein; J W Lowenthal; Y Wano; B R Franza; W C Greene
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

7.  Cloning of R kappa B, a novel DNA-binding protein that recognizes the interleukin-2 receptor alpha chain kappa B site.

Authors:  B S Adams; K Y Leung; E W Hanley; G J Nabel
Journal:  New Biol       Date:  1991-11

8.  HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.

Authors:  K Leung; G J Nabel
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

9.  High efficiency DNA-mediated transformation of primate cells.

Authors:  C Gorman; R Padmanabhan; B H Howard
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

10.  TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors.

Authors:  A Israël; O Le Bail; D Hatat; J Piette; M Kieran; F Logeat; D Wallach; M Fellous; P Kourilsky
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  83 in total

Review 1.  One path to cell death in the nervous system.

Authors:  J Glasgow; R Perez-Polo
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

Authors:  I A Udalova; A Richardson; A Denys; C Smith; H Ackerman; B Foxwell; D Kwiatkowski
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes.

Authors:  G Baier-Bitterlich; F Uberall; B Bauer; F Fresser; H Wachter; H Grunicke; G Utermann; A Altman; G Baier
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.

Authors:  M A Montano; K Kripke; C D Norina; P Achacoso; L A Herzenberg; A L Roy; G P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.

Authors:  A Ray; K E Prefontaine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.

Authors:  I C Oliveira; N Mukaida; K Matsushima; J Vilcek
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.

Authors:  H C Liou; W C Sha; M L Scott; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

8.  Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.

Authors:  J P Taylor; R J Pomerantz; G V Raj; F Kashanchi; J N Brady; S Amini; K Khalili
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  A novel gene variation of TNFalpha associated with ankylosing spondylitis: a reconfirmed study.

Authors:  Xiaoquan Zhu; Yawen Wang; Liang Sun; Yuguo Song; Fei Sun; Lei Tang; Zhenghao Huo; Jianxin Li; Ze Yang
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

10.  Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-kappa B in vivo.

Authors:  S L Eck; N D Perkins; D P Carr; G J Nabel
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.